ERBB2 and colorectal carcinoma: From the CRC transcriptome cohort, PSM allowed us to identify several well-known prognostic factors that might have been missed in traditional differential expression analysis due to confounding factors, e.g., ERBB2 (HER2), MALAT1, and MUC5AC.